STAT3 and type 2 diabetes mellitus: Baicalin regulated multiple members of the STAT family, including STAT1, STAT3, STAT4, and STAT5, for treating T2D-induced liver tumor, sepsis, and myocardial ischemia reperfusion injury (Jiang et al., 2022).